At Orthopaedic Specialists we are leading the way in using data and artificial intelligence (AI) to research and discover novel digital biomarkers that improve the precision and personalisation of surgical and non-surgical therapies for sports and acute injuries, chronic musculoskeletal pain, connective tissue disease, juvenile idiopathic arthritis and osteoarthritis.
Data-driven precision medicine supported by AI clinical studies can usher in an era of evidence-based, sustainable care, and revolutionize how data from clinical trials and registries is used to personalize and optimize treatments.
We understand the multiple sources of bias including gender, age and being a part of a less represented group. This can skew the interpretation of data. We specialise in mitigating gender-bias as we know that there is gender difference in post-operative outcomes for Orthopaedic and other MSK conditions. Despite the differences between genders, there remains a failure to incorporate sex differences in study designs and analyses.